Anzeige
Mehr »
Donnerstag, 12.02.2026 - Börsentäglich über 12.000 News
Drohnen, Robotik, E-Autos: Diese Hightech-Aktie könnte jetzt zünden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
598 Leser
Artikel bewerten:
(2)

Medsential LLC: Medsential Now Offering COVID-19 Rapid Antibody Test Kits Nationwide

SALT LAKE CITY, UT / ACCESSWIRE / April 22, 2020 / U.S.-based Medsential is now offering COVID-19 IgM/IgG rapid antibody tests beginning in April. These COVID-19 IgM/IgG testing kits will be available to laboratories and health care workers at the point-of-care under the updated guidelines issued by the FDA on March 16, 2020. Medsential is an FDA-registered medical device company and is operating in compliance with the FDA to begin distribution.

"In March, Medsential introduced antibody testing to federal and state leaders. We had early access to antibody test samples mid-March," said Chiao-ih Hui, COO of Medsential. "We knew they would be a significant game-changer to coronavirus testing across the nation. Our COVID-19 test provides results within 15 minutes on-the-spot and are easy to use. The test device is low-cost so repeat testing is cost-effective. Our test does not require any other external reading device. It requires only a finger prick."

These particular COVID-19 tests are widely used internationally and this test has CE certification in the EU. These tests are undergoing independent validation in the U.S. and Medsential has filed an EUA with the FDA. Medsential has manufacturing and distribution operations in the U.S., China and Japan and will be able to meet high-volume demand for these antibody tests.

"Our rapid test kits show three levels of antibody build-up, unlike other antibody tests that show only one," said Hui. "This allows for more accurate identification of community spread and exposure to coronavirus. Health care providers can assess the exposure of their staff and their patients to better protect vulnerable populations, including detecting COVID-19 before symptoms occur. In addition, our test can identify immunity to the virus as our bodies build up antibodies."

U.S. Sen. Orrin Hatch said, "It's critical that countries work together to solve this pandemic. That's why we've reached out to international leaders to help U.S. manufacturers and researchers in the great work they are doing to bring tests to as many Americans as possible."

"Medsential's testing kit will help broaden testing efforts so that we can slow the spread of coronavirus, and get our economy back on track," said U.S. Rep. John Curtis.

The updated FDA guidelines specifically contemplate the use of Medsential's type of IgM/IgG testing stating that "[The FDA] does not intend to object if companies start offering "serology' tests, which can infer the presence of the new coronavirus by detecting specific blood cells produced in response to the virus."

# # #

About Medsential

Medsential LLC is a U.S. company that develops, manufactures, and distributes a broad range of medical products to customers. Established in 2005, Medsential is an ISO certified medical device company with the capabilities to develop, manufacture and assemble a broad range of products. Medsential has an extensive distribution channel, sales force, engineering platform, and production team to bring quality products to global markets. We also work with partner companies to provide clinical trial tests, distribution, manufacturing, and assembly. Medsential has manufacturing and distribution operations in the U.S., China and Japan.

Learn more: www.medsential.com

For photo click here.

For b-roll footage (25MB) click here.

Contact: Press@Medsential.com

SOURCE: Medsential LLC



View source version on accesswire.com:
https://www.accesswire.com/585217/Medsential-Now-Offering-COVID-19-Rapid-Antibody-Test-Kits-Nationwide

© 2020 ACCESS Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.